If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
60.00    1.40 (2.39%)
Bid:
57.20
Ask:
60.00
Spread: 2.80 (4.895%)
Market Cap: £48.86m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Update

27 Mar 2008 07:02

Flomerics Group PLC27 March 2008 Flomerics Group PLC ("Flomerics" or "the Company") Update Flomerics, the global supplier of specialist simulation software for electronicsand fluid flow simulation, is today providing an update on its operational plansand outlook for 2008 and beyond in the light of the recent changes inshareholdings in the Company. Flomerics' strategy remains to be a leading provider of software simulationsolutions to the worldwide engineering design market. Flomerics' softwaresolutions are targeted at the world electronic thermal management and fluid flowsoftware markets. These markets are growing strongly and the Company believes it has significantopportunities for growth. For example, data published by Global IndustryAnalysts, Inc.(1) indicates that the world electronic thermal managementsoftware market will continue to grow by 10% per year over the next five years.The Company's electronics cooling business is well positioned to benefit fromthis growth, particularly in Asia and the Far-East, which has seen strong growthin recent years. Similarly, the computer-aided engineering industry is expected to grow at acompound annual growth rate of 12% through 2009(2). The Board believesFlomerics' products can outperform this average market growth rate due to thecompetitive advantages offered by its products. Strong growth has already beenseen for the Engineering Fluid Dynamics (EFD) product range in 2007 and into2008. The investment in sales and marketing in 2007, aimed at accelerating revenuegrowth particularly from the EFD product range (acquired as part of theacquisition of Nika GmbH in 2006) is beginning to show positive results. Thisreinforces the Board's confidence that 2008 revenues will show considerableimprovement over 2007. Flomerics has cash balances of approximately £5.0m compared to £2.7m as at 31December 2007, and the Company is well funded to undertake the investment neededto deliver its strategy. Following on from the acquisitions of MicReD in 2005and Nika GmbH in 2006, additional growth through targeted acquisition remains animportant focus for the Company. The board continues to review potentialcandidates against its strategic and financial targets. The Company expects to announce its preliminary results for 2007 on 29 April. Enquiries: Flomerics Group plc +44 20 8487 3000Gary Carter, Chief ExecutiveKeith Butcher, Finance Director Conduit PR +44 20 7429 6604Christian Taylor-Wilkinson, Charlie Geller +44 7970 067320 Oriel Securities Limited +44 20 7710 7600Nominated AdviserDavid ArchAndrew Edwards For further details regarding the source information used in this announcementplease contact Charlie Geller, Conduit PR, on 0207 429 6604 -------------------------- (1) Source: PRWeb(2) Source: Daratech Inc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Feb 20196:30 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading Update & Notice of Full Year Results
29th Jan 20197:00 amRNSHolding(s) in Company
23rd Jan 20199:42 amRNSChange of Registered Office
27th Nov 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSDeferred Consideration and Total Voting Rights
23rd Oct 20187:00 amRNSTrading update - nine month period ended 30.9.18
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20187:00 amRNSHolding(s) in Company
1st Oct 20183:03 pmRNS2018 Half-year Report Published
27th Sep 201812:06 pmRNSDirector/PDMR Shareholding
24th Sep 201810:02 amRNSDirector/PDMR Shareholding
20th Sep 20186:04 pmRNSDirector/PDMR Shareholding
20th Sep 20181:20 pmRNSDirector/PDMR Shareholding
18th Sep 20187:01 amRNSHalf-year Report
18th Sep 20187:00 amRNSDirectorate Changes
24th Aug 20181:57 pmRNSHolding(s) in Company- updated
23rd Aug 20183:53 pmRNSHolding(s) in Company
24th Jul 20186:24 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSGroup Trading Update & Notice of HY Results
6th Jun 201811:10 amRNSResult of AGM
6th Jun 20187:00 amRNSAGM Statement
21st May 20183:46 pmRNSHolding(s) in Company
14th May 20187:00 amRNSOption Exercise and Director's Dealings
4th May 20183:30 pmRNS2017 Annual Report - year ended 31 December 2017
27th Apr 20185:51 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSHolding(s) in Company
17th Apr 20187:01 amRNSQ1 2018 Quarter Results
17th Apr 20187:00 amRNSFinal statement of results - year ended 31.12.17
9th Apr 201811:35 amRNSHolding(s) in Company
3rd Apr 201811:24 amRNSResult of General Meeting & Total Voting Rights
26th Mar 201812:18 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSFlowtech Chairman receives FTSE AIM NED award
20th Mar 20183:16 pmRNSCompletion of the acquisition of Balu Limited
19th Mar 20182:39 pmRNSHolding(s) in Company
19th Mar 201811:52 amRNSOption Exercise and Director's Dealings
15th Mar 20187:00 amRNSPosting of circular
14th Mar 20187:00 amRNSAcquisition of Balu Ltd - Placing to raise £11m
1st Mar 201812:03 pmRNSHolding(s) in Company
26th Feb 201812:51 pmRNSHolding(s) in Company
23rd Jan 20187:00 amRNS2017 Trading Update & Notice of Full-Year Results
19th Oct 20171:54 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSQ3 Group Trading Update
12th Oct 20177:00 amRNSAcquisition of Group HES, New Division established
27th Sep 20173:57 pmRNSSilver award winner for 2017 online Annual Report
22nd Sep 20172:48 pmRNSHolding(s) in Company
19th Sep 20176:36 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSOrganic & acquisition strategy underpins future
7th Sep 20173:38 pmRNSFLOWTECH EXPANDS ITS FOOTPRINT IN EUROPE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.